The Romanian National Medicine Agency has approved the start of testing for the treatment received by Donald Trump, the US president, for his COVID-19 infection.
Adrian Streinu Cercel, the manager of the National Institute of Infectious Diseases “Matei Balş”, claims that the treatment is in the third phase of testing on people. All patients receiving this treatment will be informed that they are part of this study.
The treatment is a cocktail of monoclonal antibodies and is administered only in the early stages of infection. Studies have also shown that the treatment is safe, and so far this treatment has proven effective.
Donald Trump was diagnosed with the new coronavirus on the 1st of October. The treatment applied to him had the role of reducing the amount of virus in the body, but also the intensity of the symptoms, effects that led to the president’s rapid recovery. He was discharged after only three days.
To date, monoclonal antibody treatment is the only approved treatment against the newly coronavirus to be widely tested.
The treatment with monoclonal antibodies is produced by the pharmaceutical company Regeneron, a company recognized for innovation and research in the field. The same company also developed the treatment for Ebola.